Search

everythinglearnresearchcommunity

for

Search:↓

A holistic approach, including diet and stress management, may improve androgenetic alopecia treatment outcomes.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Clascoterone may be a promising treatment for hair loss.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Analog 23 is a promising compound for prostate cancer treatment.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Tofacitinib may help treat severe hair loss, but more research is needed.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Male pattern baldness involves hormones and cell signals affecting hair growth.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

The HR protein's role as a repressor is essential for controlling hair growth.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.